The Janus kinase 1/2 inhibitor ruxolitinib in COVID-19.

Gozzetti, Alessandro; Capochiani, Enrico; Bocchia, Monica

Gozzetti, Alessandro; Capochiani, Enrico; Bocchia, Monica.

Gozzetti A; Division of Hematology, University of Siena, Siena, Italy. gozzetti@unisi.it.
Capochiani E; Hematology Unit, Center for Translational Medicine, Azienda USL Toscana NordOvest, Livorno, Italy.
Bocchia M; Division of Hematology, University of Siena, Siena, Italy.

Leukemia ; 34(10): 2815-2816, 2020 10.

Article in English | MEDLINE | ID: covidwho-744361

Subject(s)

Coronavirus Infections; Pandemics; Pneumonia, Viral; Protein Kinase Inhibitors; Betacoronavirus; COVID-19; Janus Kinase 1; Nitriles; Pyrazoles; Pyrimidines; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pneumonia, Viral / Coronavirus Infections / Protein Kinase Inhibitors / Pandemics Language: English Journal: Leukemia Journal subject: Hematology / Neoplasms Year: 2020 Document Type: Article Affiliation country: S41375-020-01038-8

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google